期刊文献+

健康婴儿体内的无毒脆弱拟杆菌的分离及鉴定 被引量:2

Isolation and identification of a non-enterotoxigenic strain of Bacteroides fragilis from a healthy term infant
原文传递
导出
摘要 目的 对分离到的1株无毒脆弱拟杆菌进行鉴定.方法 2012年7月从健康足月新生儿的粪便中分离得到1株脆弱拟杆菌,观察其形态特征、培养特征,并进行生理生化鉴定、药敏试验及16s rRNA序列测定和分析.急慢性毒性试验检测毒性.结果 分离得到的菌株在细菌形态、培养特性、生理生化反应结果与脆弱拟杆菌相似.经BLASTN序列比对,所分离菌株与脆弱拟杆菌标准株NCTC9343同源性达99%.药敏实验提示,新分离菌株对头孢拉定、阿莫西林、庆大霉素、磺胺甲噁唑、甲氧苄啶不敏感,急慢性毒性试验提示无毒性.结论 分离的细菌为1株无毒的脆弱拟杆菌. Objective To identify a non-enterotoxigenic strain of Bacteroidesfragilis.Methods B.fragilis was isolated from the feces of a healthy full-term infant in July 2012 and identified by morphological characteristics and culture conditions,physiological and biochemical test,drug sensitivity test,16 s rRNA gene sequencing and short and long-term toxicity tests.Results The isolated bacterial strain was similar to B.fragilis in terms of morphological characteristics,culture conditions and physiological and biochemical features.The results of 16s rRNA gene sequencing demonstrated that the nucleoids of newly-isolated strain were up to 99% identical to those of standard stain of B.fragilis NCTC9343 (GenBank).The drug sensitivity test revealed that it was not sensitive to cefradine,amoxicillin,gentamicin,sulfamethoxazole and trimethoprim.And the acute and long-term toxicity tests were negative.Conclusion The isolated bacteria is a non-enterotoxigenic strain of B.fragilis.
出处 《中华医学杂志》 CAS CSCD 北大核心 2014年第30期2372-2374,共3页 National Medical Journal of China
关键词 拟杆菌 脆弱 生物学鉴定法 婴儿 Bacteroides fragilis Biological assay Infant
  • 相关文献

参考文献14

  • 1Sears CL. Enterotoxigenie bacteroidesfragilis: a rogue among symbiotes[ J]. Clin Microbiol Rev, 2009, 22:349-369.
  • 2Wick EC, Sears CL. Bacteroides spp. and diarrhea [ J ]. Curt Opin Infect Dis, 2010 , 23:470-474.
  • 3Linskens RK, Huijsdens XW, Savelkoul PH, et al. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics [ J ]. Scand J Gastroenterol Suppl, 2001, 234: 29-40.
  • 4Desreumaux P, Colombel JF. Intestinal flora and Crohn's disease [J]. Ann Pharm Fr, 2003 ,61 : 276-281.
  • 5Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease[ J]. Nature, 2008, 453:620-625.
  • 6布坎南 R E,吉本斯 N E.伯杰细菌鉴定手册[M].8 版,北京: 科学出版社,1984.
  • 7何明清 谢镜怀 朱玉兰 等.病、健仔猪不同肠段菌群的研究.畜牧兽医学报,1986,17(4):276-276.
  • 8冉文斌,欧阳钦,史维.克罗恩病患者黏膜相关细菌群落多样性分析[J].中华医学杂志,2013,93(36):2884-2889. 被引量:3
  • 9Mazmanian SK, Liu CH, Tzianabos AO, et al. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system [ J ]. Cell, 2005, 122 : 107- 118.
  • 10Round JL, Lee SM, Li J, et al. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota [ J]. Science , 2011, 332:974-977.

二级参考文献20

  • 1Cosnes J, Gower-Rousseau C, Seksik P, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology, 2011, 140:1785-1794.
  • 2Bernstein CN, Fried M, Krabshuis JH, et al. World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. Inflamm Bowel Dis, 2010, 16: 112-124.
  • 3Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med, 2009. 361,2066-2078_.
  • 4中华医学会消化病学分会炎症性肠病组.炎症性肠病诊断与治疗的共识意见(2012·广州).胃肠病学,2012,17:763G81.
  • 5Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med, 2010, 362:1383-1395.
  • 6Sepehri S, Kotlowski R, Bernstein CN, et al. Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease. Inflamm Bowel Dis, 2007, 13:675-683.
  • 7Engebretson JJ, Moyer CL. Fidelity of select restriction endonucleases in determining microbial diversity by terminal- restriction fragment length polymorphism. Appl Environ Microbiol, 2003, 69:4823-4829.
  • 8Hayashi H, Takahashi R, Nishi T, et al. Molecular analysis of jejunal, ileal, eaeeal and recto-sigmoidal human colonic mierobiota using 16S rRNA gene libraries and terminal restriction fragment length polymorphism. J Med Microbiol, 2005, 54 : 1093-1101.
  • 9Berg RD. The indigenous gastrointestinal microflora. Trends Mierobiol, 1996, 4:430-435.
  • 10Kohyama A, Ogawa H, Funayama Y, et al. Bacterial population moves toward a colon-like community in the pouch after total proctoeoleetomy. Surgery, 2009, 145:435447.

共引文献23

同被引文献54

  • 1张季阶,张洪梅,张翼,张洪桂,毕邻,张秀晨,张洪正,徐桂兰,徐灵芝.脆弱拟杆菌(BF839)菌液的临床应用研究[J].中国生物制品学杂志,1995,8(2):63-65. 被引量:7
  • 2李华,郭红延,林红兰,田春娟,冯俊敏.替硝唑根管冲洗液临床效果评价[J].牙体牙髓牙周病学杂志,2006,16(9):529-530. 被引量:9
  • 3布坎南RE.伯杰氏细菌鉴定手册[M].第8版.北京:科学出版社,1984:677-830.
  • 4Nana YD, Jung MJ, Roh SW, et al. Comparative analysis of Korean human gut microbiota by barcoded pyrosequencing[J]. PLoS One, 2011, 6(7): e22109.
  • 5Xu J, Bjursell MK, Himrod J, et al. A genomic view of the human-Bacteroides thetaiotaomicron symbiosis[J]. Science, 2003, 299(5615): 2074-2076.
  • 6Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis[J]. Cell, 2004, 118(2): 229-241.
  • 7Btickhed F, Ley RE, Sormenbug JL, et al. Host-bacterial mutualism in the human intestine[J]. Science, 2005, 307(5717): 1915-1920.
  • 8LeBlanc JG, Milani C, de Giori GS, et aL Bacteria as vitamin suppliers to their host: a gut microbiotaperspective[J]. Current Opinion in Biotechnology, 2013, 24(2): 160-168.
  • 9Sears CL. A dynamic partnership: celebrating our gut flora[J]. Anaerobe, 2005, 11 (5): 247-251.
  • 10Ochoa-Repfiraz J, Mielcarz DW, Wang Y, et al. A polysaccharide from the human commensal Bacteroidesfragilis protects against CNS demyelinating disease[J]. Mucosal Immunology, 2010, 3(5) 487-495.

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部